3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers, 13 USDMF, 6 EU WC, 5 KDMF, 10 NDC API, 16 Listed Suppliers

DEVELOPMENTS

63 Drug(s) in Development

63 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

44 Dossiers, 22 FDA Orange Book, 12 Europe, 2 Canada, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MCG, TABLET;ORAL - 500MCG

RELATED EXCIPIENT COMPANIES

Suppliers, 15 Kerry, 9 BASF, 8 Microlex e.U, 6 Roquette, 5 Gangwal Healthcare, 3 SPI Pharma, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ingredion Pharma Solutions, 2 Sigachi Industries, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 DFE Pharma, 1 Pharmatrans-Sanaq, 1 Seppic, 1 Gangwal Chemicals, 1 Vasa Pharmachem, 1 Prachin Chemical, 1 Nanjing Well Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 15 Direct Compression, 10 Granulation, 8 Lubricants & Glidants, 7 Solubilizers, 6 Disintegrants & Superdisintegrants, 6 Co-Processed Excipients, 5 Controlled & Modified Release, 3 Parenteral, 3 Chewable & Orodispersible Aids, 3 Thickeners and Stabilizers, 3 Taste Masking, 2 Coating Systems & Additives, 1 Film Formers & Plasticizers, 1 Emulsifying Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Finished Drug Prices

MARKET PLACE

13 APIs, 1 DOSSIERS // FDF

PATENTS

21 US Patents, 3 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 84 News

3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
HEALTH CANADA PATENTS
Full Screen View

Information, Expiry & Status of Health Canada Patents covering 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE.

3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers

13 USDMF

6 EU WC

5 KDMF

10 NDC API

16 Listed Suppliers

DEVELOPMENTS

63 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

44 Dossiers

22 FDA Orange Book

12 Europe

2 Canada

1 South Africa

7 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MCG

TABLET;ORAL - 500MCG

RELATED EXCIPIENT COMPANIES

Suppliers

15 Kerry

9 BASF

8 Microlex e.U

6 Roquette

5 Gangwal Healthcare

3 SPI Pharma

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ingredion Pharma Solutions

2 Sigachi Industries

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 DFE Pharma

1 Pharmatrans-Sanaq

1 Seppic

1 Gangwal Chemicals

1 Vasa Pharmachem

1 Prachin Chemical

1 Nanjing Well Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders

15 Direct Compression

10 Granulation

8 Lubricants & Glidants

7 Solubilizers

6 Disintegrants & Superdisintegrants

6 Co-Processed Excipients

5 Controlled & Modified Release

3 Parenteral

3 Chewable & Orodispersible Aids

3 Thickeners and Stabilizers

3 Taste Masking

2 Coating Systems & Additives

1 Film Formers & Plasticizers

1 Emulsifying Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

11 Finished Drug Prices

MARKET PLACE

13 APIs

1 DOSSIERS // FDF

PATENTS

21 US Patents

3 US Exclusivities

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

DIGITAL CONTENT